Comparison of Patients With MTC Diagnosis and Treated Before and After 1996
| Characteristic . | Before 1996 . | After 1996 . | P Value . |
|---|---|---|---|
| Patients, n | 103 | 157 | |
| Stage, n (%) | < 0.0001a | ||
| 0 | 5 (4.9) | 42 (26.8) | |
| I | 26 (25.2) | 56 (35.7) | |
| II | 29 (28.2) | 17 (10.8) | |
| III | 36 (35.0) | 31 (19.8) | |
| IV | 7 (6.8) | 11 (7.0) | |
| 10-y Survival, % | Before 1996, 0.0005b; after 1996, 0.63b | ||
| MOD | 85 | 92 | |
| H | 93 | 96 | |
| HST | 67 | 89 | |
| Outcome | |||
| Cured, n/N (%) | 0.0017a | ||
| MOD | 8/31 (25.8) | 61/91 (67.8) | |
| H | 27/62 (42.6) | 45/56 (80.3) | |
| HST | 1/10 (10) | 2/11 (18.1) | |
| Death, n/N (%) | 0.298a | ||
| MOD | 4/31 (12.9) | 4/91(4.4) | |
| H | 6/62 (9.7) | 2/56 (3.6) | |
| HST | 6/10 (60) | 1/11 (9.1) |
| Characteristic . | Before 1996 . | After 1996 . | P Value . |
|---|---|---|---|
| Patients, n | 103 | 157 | |
| Stage, n (%) | < 0.0001a | ||
| 0 | 5 (4.9) | 42 (26.8) | |
| I | 26 (25.2) | 56 (35.7) | |
| II | 29 (28.2) | 17 (10.8) | |
| III | 36 (35.0) | 31 (19.8) | |
| IV | 7 (6.8) | 11 (7.0) | |
| 10-y Survival, % | Before 1996, 0.0005b; after 1996, 0.63b | ||
| MOD | 85 | 92 | |
| H | 93 | 96 | |
| HST | 67 | 89 | |
| Outcome | |||
| Cured, n/N (%) | 0.0017a | ||
| MOD | 8/31 (25.8) | 61/91 (67.8) | |
| H | 27/62 (42.6) | 45/56 (80.3) | |
| HST | 1/10 (10) | 2/11 (18.1) | |
| Death, n/N (%) | 0.298a | ||
| MOD | 4/31 (12.9) | 4/91(4.4) | |
| H | 6/62 (9.7) | 2/56 (3.6) | |
| HST | 6/10 (60) | 1/11 (9.1) |
Comparison of Patients With MTC Diagnosis and Treated Before and After 1996
| Characteristic . | Before 1996 . | After 1996 . | P Value . |
|---|---|---|---|
| Patients, n | 103 | 157 | |
| Stage, n (%) | < 0.0001a | ||
| 0 | 5 (4.9) | 42 (26.8) | |
| I | 26 (25.2) | 56 (35.7) | |
| II | 29 (28.2) | 17 (10.8) | |
| III | 36 (35.0) | 31 (19.8) | |
| IV | 7 (6.8) | 11 (7.0) | |
| 10-y Survival, % | Before 1996, 0.0005b; after 1996, 0.63b | ||
| MOD | 85 | 92 | |
| H | 93 | 96 | |
| HST | 67 | 89 | |
| Outcome | |||
| Cured, n/N (%) | 0.0017a | ||
| MOD | 8/31 (25.8) | 61/91 (67.8) | |
| H | 27/62 (42.6) | 45/56 (80.3) | |
| HST | 1/10 (10) | 2/11 (18.1) | |
| Death, n/N (%) | 0.298a | ||
| MOD | 4/31 (12.9) | 4/91(4.4) | |
| H | 6/62 (9.7) | 2/56 (3.6) | |
| HST | 6/10 (60) | 1/11 (9.1) |
| Characteristic . | Before 1996 . | After 1996 . | P Value . |
|---|---|---|---|
| Patients, n | 103 | 157 | |
| Stage, n (%) | < 0.0001a | ||
| 0 | 5 (4.9) | 42 (26.8) | |
| I | 26 (25.2) | 56 (35.7) | |
| II | 29 (28.2) | 17 (10.8) | |
| III | 36 (35.0) | 31 (19.8) | |
| IV | 7 (6.8) | 11 (7.0) | |
| 10-y Survival, % | Before 1996, 0.0005b; after 1996, 0.63b | ||
| MOD | 85 | 92 | |
| H | 93 | 96 | |
| HST | 67 | 89 | |
| Outcome | |||
| Cured, n/N (%) | 0.0017a | ||
| MOD | 8/31 (25.8) | 61/91 (67.8) | |
| H | 27/62 (42.6) | 45/56 (80.3) | |
| HST | 1/10 (10) | 2/11 (18.1) | |
| Death, n/N (%) | 0.298a | ||
| MOD | 4/31 (12.9) | 4/91(4.4) | |
| H | 6/62 (9.7) | 2/56 (3.6) | |
| HST | 6/10 (60) | 1/11 (9.1) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
